Anti-Depressant

XTAZ 5

Description

The high rates of coexisting anxiety disorders and depression, presents considerable clinical challenge in treating it. The 2 main categories of medication used in the treatment of anxiety disorders are benzodiazepines and Selective serotonin reuptake inhibitors (SSRIs).SSRIs are considered first-line therapy in managing depression.The primary limitations of SSRIs involve , delay in onset of effect (Few weeks) & the risk of agitation and anxiety at the initiation of treatment .These factors contribute to reduced adherence to treatment and poorer outcomes.Increased anxiety associated with the initiation of antidepressant therapy, increases patients' distress, which may lead to thoughts of suicide. Concomitant use of benzodiazepines like clonazepam is useful in reducing agitation and anxiety & also it has got rapid onset of action.

The high rates of coexisting anxiety disorders and depression, presents considerable clinical challenge in treating it. The 2 main categories of medication used in the treatment of anxiety disorders are benzodiazepines and Selective serotonin reuptake inhibitors (SSRIs).SSRIs are considered first-line therapy in managing depression.The primary limitations of SSRIs involve , delay in onset of effect (Few weeks) & the risk of agitation and anxiety at the initiation of treatment .These factors contribute to reduced adherence to treatment and poorer outcomes.Increased anxiety associated with the initiation of antidepressant therapy, increases patients' distress, which may lead to thoughts of suicide. Concomitant use of benzodiazepines like clonazepam is useful in reducing agitation and anxiety & also it has got rapid onset of action.